YF476 in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome

Condition:   CarcinoidIntervention:   Drug: YF476Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting - verified March 2015

Source: ClinicalTrials.gov - March 23, 2011 Category: Research Source Type: clinical trials